SCHEMBL6448770

SCHEMBL6448770

COC(=O)NCCCCCCO

nearest known ligand 0.69

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
EPHX1 P07099 1/20 0.69
TDP1 Q9NUW8 1/20 0.66
ACHE P22303 13/20 0.56
POLB P06746 1/20 0.49
KDM4E B2RXH2 1/20 0.46
MAPK1 P28482 1/20 0.46
HIF1A Q16665 1/20 0.46
NAAA Q02083 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14439354 1.00 EPHX1 (0.69) EPHX1TDP1ACHEPOLBKDM4E
SCHEMBL4790564 0.98 EPHX1 (0.65) EPHX1TDP1ACHEPOLBKDM4E
SCHEMBL7369867 0.91
SCHEMBL717081 0.91 EPHX1 (0.82) EPHX1TDP1ACHEKDM4EMAPK1
SCHEMBL7788937 0.91 EPHX1 (0.82) EPHX1TDP1ACHEKDM4EMAPK1
SCHEMBL14252129 0.91 EPHX1 (0.82) EPHX1TDP1ACHEKDM4EMAPK1
SCHEMBL7788569 0.91 EPHX1 (0.82) EPHX1TDP1ACHEKDM4EMAPK1
SCHEMBL7788927 0.91 EPHX1 (0.82) EPHX1TDP1ACHEKDM4EMAPK1
SCHEMBL7252127 0.88 EPHX1 (0.77) EPHX1TDP1ACHEKDM4EMAPK1
SCHEMBL23735485 0.84 EPHX1 (0.72) EPHX1TDP1ACHEKDM4EMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260090547-A1 BIO-INSECTICIDES FROM WASTE BIOMASS UNIVERSITY OF DELAWARE (US) 2026-04-02 US disclosed
WO-2025015272-A2 BIO-INSECTICIDES FROM WASTE BIOMASS UNIVERSITY OF DELAWARE (US) 2025-01-16 WO disclosed
US-20100304367-A1 COMPOSITIONS FOR REAL-TIME, SINGLE MOLECULE SEQUENCE DETERMINATION Life Technologies Corporation (US) 2010-12-02 US disclosed
US-20100255463-A1 Compositions and methods for sequence determination HARSIN SUSAN 2010-10-07 US disclosed
US-20090305278-A1 SEQUENCE DETERMINATION IN CONFINED REGIONS Life Technologies Corporation (US) 2009-12-10 US disclosed
US-20090275036-A1 SYSTEMS AND METHODS FOR REAL TIME SINGLE MOLECULE SEQUENCE DETERMINATION Life Technologies Corporation (US) 2009-11-05 US disclosed
US-7329492-B2 Engineering a polymerase and/or dNTPs with atomic and/or molecular tags that have a detectable property that is monitored by a detection system VISIGEN BIOTECHNOLOGIES, INC. (US) 2008-02-12 US disclosed
US-20070292867-A1 Sequence determination using multiply tagged polymerizing agents HARDIN SUSAN 2007-12-20 US disclosed
US-20070275395-A1 Tagged monomers for use in sequence determination HARDIN SUSAN 2007-11-29 US disclosed
US-20070172868-A1 Compositions for sequence determination using tagged polymerizing agents and tagged monomers HARDIN SUSAN 2007-07-26 US disclosed
US-20070172866-A1 Methods for sequence determination using depolymerizing agent HARDIN SUSAN 2007-07-26 US disclosed
US-20070172862-A1 Data stream determination HARDIN SUSAN 2007-07-26 US disclosed
US-20070172863-A1 Compositions and methods for sequence determination HARDIN SUSAN 2007-07-26 US disclosed
US-20070172861-A1 Mutant polymerases HARDIN SUSAN 2007-07-26 US disclosed
US-20070172867-A1 Methods for sequence determination HARDIN SUSAN 2007-07-26 US disclosed
US-20070172865-A1 Sequence determination in confined regions HARDIN SUSAN 2007-07-26 US disclosed
US-20070172858-A1 Methods for sequence determination HARDIN SUSAN 2007-07-26 US disclosed
US-6929685-B2 Alkylamine derivatives as antifouling agents BAYER ATIENGESELLSCHAFT (DE) 2005-08-16 US disclosed
US-20040118318-A1 Alkylamine derivatives as antifouling agents LANXESS DEUTSCHLAND GMBH (DE) 2004-06-24 US disclosed
EP-1245558-A1 Alkylamine derivates as anti-fouling agents Bayer Aktiengesellschaft (DE) 2002-10-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070172861-A1 Mutant polymerases POLM, POLRMT, RNGTT EPHX1 3890/4885TDP1 106/4885ACHE 3767/4885
US-20260090547-A1 BIO-INSECTICIDES FROM WASTE BIOMASS PTMS, DDT, BCHE EPHX1 935/4885TDP1 3577/4885ACHE 5/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.